Back to search results

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

Abroad (travel likely)RecruitingPHASE3

Conditions

Severe Alopecia Areata

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • California Dermatology & Clinical Research Institute, Encinitas, California, United States

  • Pediatric Skin Research, Miami, Florida, United States

  • D&H Tamarac Research Center, Tamarac, Florida, United States

  • Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, United States

  • Kindred Hair and Skin Center, Marriottsville, Maryland, United States

  • Michigan Dermatology Institute, Waterford, Michigan, United States

  • Ear, Nose & Throat Consultants, LLC, Omaha, Nebraska, United States

  • Skin Specialists, PC dba Schlessinger MD, Omaha, Nebraska, United States

  • Complete Behavior Health (Dr. Brittany Marshall, Licensed Psychologist), Papillion, Nebraska, United States

  • University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States

  • University of New Mexico-IDS Pharmacy, Albuquerque, New Mexico, United States

  • Regents of the University of New Mexico, Albuquerque, New Mexico, United States

  • Equity Medical, LLC, The Bronx, New York, United States

  • Northwest Dermatology Institute, Portland, Oregon, United States

  • Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

  • Medical University of South Carolina Department of Dermatology and Dermatologic Surgery, Charleston, South Carolina, United States

  • 3A Research, El Paso, Texas, United States

  • Texas Dermatology and Laser Specialists, San Antonio, Texas, United States

  • Huashan Hospital, Fudan University, Shanghai, Shanghai Municipality, China

  • Prof. MUDr. Petr Arenberger, DrSc., MBA, Prague, Czechia

  • Hospices Civils de Lyon - Hopital Femme Mere Enfant, Bron, France

  • CHU de Dijon Bourgogne, Dijon, France

  • GHICL - Service d'investigation - Recherche clinique, Lille, France

  • Hôpital Saint Vincent de Paul, Lille, France

  • Centre Hospitalier Universitaire de Nice, Nice, France

  • Hôpitaux Drôme Nord, Romans-sur-Isère, France

  • Centre Hospitalier Universitaire de Toulouse - Hôpital Larrey, Toulouse, France

  • Tohoku University Hospital, Sendai, Miyagi, Japan

  • Hamamatsu University Hospital, Hamamatsu, Shizuoka, Japan

  • Kyorin University Hospital, Mitaka, Tokyo, Japan

  • Osaka Metropolitan University Hospital, Osaka, Japan

  • Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Spółka Partnerska, Wroclaw, Lower Silesian Voivodeship, Poland

  • DERMEDIC Iwona Zdybska, Lublin, Lublin Voivodeship, Poland

  • Klinika Osipowicz & Turkowski, Warsaw, Masovian Voivodeship, Poland

  • Państwowy Instytut Medyczny MSWiA, Warsaw, Masovian Voivodeship, Poland

  • Provita Poliklinika, Warsaw, Masovian Voivodeship, Poland

  • Klinika Ambroziak Dermatologia, Warsaw, Masovian Voivodeship, Poland

  • Royalderm Agnieszka Nawrocka, Warsaw, Masovian Voivodeship, Poland

  • Centrum Medyczne Angelius Provita, Katowice, Silesian Voivodeship, Poland

  • Uniwersytecki Szpital kliniczny im. F. Chopina w Rzeszowie, Rzeszów, Poland

  • Dermoklinika - Centrum Medyczne spółka cywilna M. Kierstan, J. Narbutt, A. Lesiak, Lodz, Łódź Voivodeship, Poland

Study leads

  • Pfizer CT.gov Call Center

    Study Director

    Pfizer

View source on ClinicalTrials.gov(opens in a new tab)